BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 4
• 5
• 6
• 7
• 8
• 11
• 12
• 13
• 14
• 15
• 16
• 18
• 19
• 20
• 21
• 22
• 25
• 26
• 27
• 28
• 29

• Business

  Trius Therapeutics Announces Issuance of Key U.S. Patent for Torezolid Phosphate

  October 26, 2010

   · 

  3 min read
• Drug Development

  Celator Pharmaceuticals, Inc. Completes Enrollment in a Second Phase 2 Trial of CPX-351 in Acute Myeloid Leukemia

  October 26, 2010

   · 

  4 min read
• Business

  Stereotaxis, Inc. Announces Third Quarter 2010 Earnings Release Date and Conference Call

  October 26, 2010

   · 

  3 min read
• Drug Development

  Tengion Inc. Presents New Large Animal Data Demonstrating Functional Kidney Regeneration at the American Society for Transplantation Annual Conference

  October 26, 2010

   · 

  5 min read
• Policy

  Emdeon Corporation Clinician Achieves Meaningful Use Certification

  October 26, 2010

   · 

  5 min read
• Biotech Bay

  Accuray Inc. to Speak at Oppenheimer’s 21st Annual Healthcare Conference

  October 26, 2010

   · 

  1 min read
• Business

  Centene Corporation Reports $0.44 Earnings Per Diluted Share for the Third Quarter 2010; $0.48 From Operations Excluding a $0.04 Charge for Net Investment Writedowns

  October 26, 2010

   · 

  5 min read
• Policy

  FDA Laboratory Receives Accreditation

  October 26, 2010

   · 

  1 min read
• Drug Development

  Nautilus Neurosciences, Inc.: New Analysis of CAMBIA(TM) Pivotal Data to be Presented at the 4th World Congress on Controversies in Neurology

  October 26, 2010

   · 

  4 min read
• Drug Development

  PTC Therapeutics, Inc. Initiates Phase 2 Clinical Trial of Ataluren in Patients With Methylmalonic Acidemia

  October 26, 2010

   · 

  5 min read